• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[预后营养指数对晚期非小细胞肺癌合并恶性胸腔积液患者预后及自发性胸膜固定术的预测价值]

[Predictive Value of Prognostic Nutritional Index in Prognosis and 
Spontaneous Pleurodesis of Patients with Advanced Non-small Cell Lung Cancer 
and Malignant Pleural Effusion].

作者信息

Tan Sihan, Li Weimin, Tian Panwen

机构信息

Department of Pulmonary and Critical Care Medicine/Lung Cancer Institute, State Key Laboratory of Respiratory Health and 
Multimorbidity, Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, 
Chengdu 610041, China.

出版信息

Zhongguo Fei Ai Za Zhi. 2024 Dec 20;27(12):931-939. doi: 10.3779/j.issn.1009-3419.2024.106.33.

DOI:10.3779/j.issn.1009-3419.2024.106.33
PMID:39962848
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11843482/
Abstract

BACKGROUND

A prognostic nutritional index (PNI) developed by nutritional status and inflammation are closely associated with poor prognosis in malignant tumors. However, the predictive impact of PNI in patients with malignant pleural effusion (MPE) remains inconclusive. The study aimed to determine the predictive value of PNI in prognosis and spontaneous pleurodesis among patients with MPE.

METHODS

The patients diagnosed with advanced non-small cell lung cancer (NSCLC) with MPE in West China Hospital between January 2015 and December 2022 were reviewed and allocated randomly to development set(60%) and validation set(40%). After collecting clinical data, peripheral blood inflammation indices and calculating systemic inflammation indices, the effects of PNI on prognosis and spontaneous pleurodesis have been evaluated by Cox proportional hazards models, Kaplan-Meier method and Nelson-Aalen cumulative risk curve.

RESULTS

In total, 261 patients diagnosed NSCLC with MPE were selected (development set: n=157; validation set: n=104), of whom 58.2% were aged <65 years, 53.6% were male and 95.8% were diagnosed with adenocarcinoma. The dichotomous cut-off value for PNI was 44.1, respectively. Compared with lower PNI (PNI<44.1) cases, patients with higher PNI (PNI≥44.1) showed significantly longer overall survival (36.5 vs 24.3 mon, P=0.02) and higher incidence of spontaneous pleurodesis (P=0.009). According to the multivariate Cox analysis, higher PNI was associated with good prognosis and successful spontaneous pleurodesis (P<0.05). According to the results of Cox regression analysis, the PNI-prognosis and PNI-spontaneous pleurodesis models are determined, the receiver operating characteristic (ROC) curves are drawn, and the area under the curves (AUC) value of development set are 0.694 (95%CI: 0.620-0.776) and 0.673 (95%CI: 0.590-0.737).

CONCLUSIONS

PNI is a reliable biomarker of prognosis and spontaneous pleurodesis in patients with MPE. Attention to the patient's nutritional status and inflammation may improve the prognosis and efficacy of pleural effusion.

摘要

背景

由营养状况和炎症指标制定的预后营养指数(PNI)与恶性肿瘤的不良预后密切相关。然而,PNI对恶性胸腔积液(MPE)患者的预测价值仍不明确。本研究旨在确定PNI在MPE患者预后及胸膜固定术中的预测价值。

方法

回顾性分析2015年1月至2022年12月在华西医院诊断为晚期非小细胞肺癌(NSCLC)并伴有MPE的患者,并随机分为训练集(60%)和验证集(40%)。收集临床资料、外周血炎症指标并计算全身炎症指标后,采用Cox比例风险模型、Kaplan-Meier法和Nelson-Aalen累积风险曲线评估PNI对预后和胸膜固定术的影响。

结果

共纳入261例诊断为NSCLC并伴有MPE的患者(训练集:n = 157;验证集:n = 104),其中58.2%年龄<65岁,53.6%为男性,95.8%诊断为腺癌。PNI的二分法临界值分别为44.1。与PNI较低(PNI<44.1)的患者相比,PNI较高(PNI≥44.1)的患者总生存期显著更长(36.5个月对24.3个月,P = 0.02),胸膜固定术发生率更高(P = 0.009)。多因素Cox分析显示,较高的PNI与良好的预后和成功的胸膜固定术相关(P<0.05)。根据Cox回归分析结果,确定了PNI-预后和PNI-胸膜固定术模型,绘制了受试者工作特征(ROC)曲线,训练集的曲线下面积(AUC)值分别为0.694(95%CI:0.620 - 0.776)和0.673(95%CI:0.590 - 0.737)。

结论

PNI是MPE患者预后和胸膜固定术的可靠生物标志物。关注患者的营养状况和炎症反应可能改善胸腔积液的预后和疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1965/11843482/ae3766f25942/zgfazz-27-12-931-img_3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1965/11843482/510959fd0fad/zgfazz-27-12-931-img_1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1965/11843482/f0e9cc4a1056/zgfazz-27-12-931-img_2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1965/11843482/ae3766f25942/zgfazz-27-12-931-img_3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1965/11843482/510959fd0fad/zgfazz-27-12-931-img_1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1965/11843482/f0e9cc4a1056/zgfazz-27-12-931-img_2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1965/11843482/ae3766f25942/zgfazz-27-12-931-img_3.jpg

相似文献

1
[Predictive Value of Prognostic Nutritional Index in Prognosis and 
Spontaneous Pleurodesis of Patients with Advanced Non-small Cell Lung Cancer 
and Malignant Pleural Effusion].[预后营养指数对晚期非小细胞肺癌合并恶性胸腔积液患者预后及自发性胸膜固定术的预测价值]
Zhongguo Fei Ai Za Zhi. 2024 Dec 20;27(12):931-939. doi: 10.3779/j.issn.1009-3419.2024.106.33.
2
Bevacizumab plus chemotherapy in nonsquamous non-small cell lung cancer patients with malignant pleural effusion uncontrolled by tube drainage or pleurodesis: A phase II study North East Japan Study group trial NEJ013B.贝伐珠单抗联合化疗治疗恶性胸腔积液经引流或胸膜固定术控制不佳的非鳞状非小细胞肺癌患者:东北日本研究组试验 NEJ013B 的 II 期研究。
Thorac Cancer. 2020 Jul;11(7):1876-1884. doi: 10.1111/1759-7714.13472. Epub 2020 May 18.
3
Predictors for spontaneous pleurodesis in patients with indwelling pleural catheters for malignant pleural effusion: a safety net hospital experience.恶性胸腔积液留置胸腔导管患者自发性胸膜固定术的预测因素:一家安全网医院的经验
Ther Adv Respir Dis. 2025 Jan-Dec;19:17534666251318844. doi: 10.1177/17534666251318844.
4
Diagnostic and prognostic values of endothelial-cell-specific molecule-1 with malignant pleural effusions in patients with non-small cell lung cancer.内皮细胞特异性分子-1对非小细胞肺癌患者恶性胸腔积液的诊断及预后价值
Oncotarget. 2017 Jul 25;8(30):49217-49223. doi: 10.18632/oncotarget.17455.
5
Development a predictive nomogram for spontaneous pleurodesis in patients with non-small cell lung cancer and malignant pleural effusion.开发一种用于预测非小细胞肺癌合并恶性胸腔积液患者自发性胸膜固定术的列线图。
J Thorac Dis. 2025 Feb 28;17(2):1013-1027. doi: 10.21037/jtd-2025-31. Epub 2025 Feb 27.
6
Predictive value of inflammation and nutritional index in immunotherapy for stage IV non-small cell lung cancer and model construction.炎症和营养指标对 IV 期非小细胞肺癌免疫治疗的预测价值及模型构建。
Sci Rep. 2024 Jul 30;14(1):17511. doi: 10.1038/s41598-024-66813-4.
7
Measurement and immunophenotyping of pleural fluid EpCAM-positive cells and clusters for the management of non-small cell lung cancer patients.测量和免疫表型分析胸腔积液中 EpCAM 阳性细胞和细胞簇,以管理非小细胞肺癌患者。
Lung Cancer. 2019 Jan;127:25-33. doi: 10.1016/j.lungcan.2018.11.020. Epub 2018 Nov 19.
8
Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer.初诊时恶性胸腔积液对转移性非小细胞肺癌患者预后的影响。
J Thorac Oncol. 2012 Oct;7(10):1485-9. doi: 10.1097/JTO.0b013e318267223a.
9
The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non-small cell lung cancer treated with platinum-based chemotherapeutics.预后营养指数(PNI)和中性粒细胞与淋巴细胞比值(NLR)对铂类化疗治疗晚期非小细胞肺癌的预后价值。
Ann Palliat Med. 2020 May;9(3):967-978. doi: 10.21037/apm.2020.04.31. Epub 2020 Apr 21.
10
A phase II study of bevacizumab with carboplatin-pemetrexed in non-squamous non-small cell lung carcinoma patients with malignant pleural effusions: North East Japan Study Group Trial NEJ013A.贝伐单抗联合卡铂-培美曲塞治疗伴有恶性胸腔积液的非鳞状非小细胞肺癌患者的II期研究:日本东北研究组试验NEJ013A
Lung Cancer. 2016 Sep;99:131-6. doi: 10.1016/j.lungcan.2016.07.003. Epub 2016 Jul 5.

本文引用的文献

1
Understanding cachexia and its impact on lung cancer and beyond.了解恶病质及其对肺癌及其他方面的影响。
Chin Med J Pulm Crit Care Med. 2024 Mar 20;2(2):95-105. doi: 10.1016/j.pccm.2024.02.003. eCollection 2024 Jun.
2
The advanced lung cancer inflammation index (ALI) predicted the postoperative survival rate of patients with non-small cell lung cancer and the construction of a nomogram model.高级肺癌炎症指数 (ALI) 预测了非小细胞肺癌患者的术后生存率和列线图模型的构建。
World J Surg Oncol. 2024 Jun 14;22(1):158. doi: 10.1186/s12957-024-03432-3.
3
Combining dynamics of serum inflammatory and nutritional indicators as novel biomarkers in immune checkpoint inhibitor treatment of non-small-cell lung cancer with bone metastases.
将血清炎症和营养指标的动态变化作为免疫检查点抑制剂治疗伴有骨转移的非小细胞肺癌的新型生物标志物。
Int Immunopharmacol. 2024 Jul 30;136:112276. doi: 10.1016/j.intimp.2024.112276. Epub 2024 May 30.
4
Pre-Operative Measures of Systemic Inflammation Predict Survival After Surgery for Primary Lung Cancer.系统性炎症的术前测量可预测原发性肺癌手术后的生存率。
Clin Lung Cancer. 2024 Jul;25(5):460-467.e7. doi: 10.1016/j.cllc.2024.04.018. Epub 2024 May 8.
5
Risk factors for symptomatic malignant pleural effusion recurrence in patients with actionable mutations in advanced lung adenocarcinoma.晚期肺腺癌具有可操作突变患者发生有症状恶性胸腔积液复发的危险因素。
Transl Lung Cancer Res. 2023 Sep 28;12(9):1887-1895. doi: 10.21037/tlcr-23-151. Epub 2023 Sep 1.
6
The prognostic impact of pre-treatment cachexia in resectional surgery for oesophagogastric cancer: a meta-analysis and meta-regression.术前恶病质对食管胃结合部癌切除术预后影响的荟萃分析和荟萃回归。
Br J Surg. 2023 Nov 9;110(12):1703-1711. doi: 10.1093/bjs/znad239.
7
The relationship of nutritional status with anticancer immunity and its prognostic value for head and neck cancer.营养状况与抗肿瘤免疫的关系及其对头颈部癌症预后的价值。
Mol Carcinog. 2023 Sep;62(9):1388-1398. doi: 10.1002/mc.23584. Epub 2023 Jun 2.
8
Assessing Factors That May Impact Physician-based Decisions for Placing Indwelling Pleural Catheters.评估可能影响医生决定留置胸腔导管的因素。
9
T cell-related prognostic risk model and tumor immune environment modulation in lung adenocarcinoma based on single-cell and bulk RNA sequencing.基于单细胞和批量RNA测序的肺腺癌T细胞相关预后风险模型及肿瘤免疫环境调控
Comput Biol Med. 2023 Jan;152:106460. doi: 10.1016/j.compbiomed.2022.106460. Epub 2022 Dec 21.
10
Identification and validation of a prognostic risk-scoring model based on sphingolipid metabolism-associated cluster in colon adenocarcinoma.基于结直肠腺癌中鞘脂代谢相关簇的预后风险评分模型的鉴定和验证。
Front Endocrinol (Lausanne). 2022 Nov 28;13:1045167. doi: 10.3389/fendo.2022.1045167. eCollection 2022.